Comparative Risk of Venous Thromboembolism with Tofacitinib versus Tumour Necrosis Factor Inhibitor: A Cohort study of Rheumatoid Arthritis Patients
Desai RJ, et al. Arthritis Rheumatol. 2019 June;71(6):892-900.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Desai RJ, et al. Arthritis Rheumatol. 2019 June;71(6):892-900.
Please click the links below to go to the CSF review of each paper
Pharmacoeconomics. 2018 Dec;36(12):1427-1437. doi: 10.1007/s40273-018-0677-7
Ann Rheum Dis 2018; 77:650–57 DOI: 10.1136/annrheumdis-2017-212395
Pharmacoeconomics 2018 Jul; 36(7):769–78
Pharmacoeconomics 2018 Sep; 36(9): 1063–72
Arthritis Res Ther 2018; 20(1):60 doi: 10.1186/s13075-018-1539-6
Rheumatology (Oxford) 2018 May; 57(5):900-908
N Engl J Med 2017;377:1525–36.